The Population Research Core (PopRC) is a new shared resource for the HCCC. The Population Research Core is designed to assist HCCC members in conducting the highest quality genetic, epidemiologic, behavioral, applied, and surveillance cancer research based on enhancing access to, and connection between, large population databases. Its basic function is to serve as a resource to HCCC investigators who want to extend research findings to specific populations and who want to explore other population-based research questions. More specifically, the Population Research Core provides access for HCCC to: ? lowa Cancer Registry surveillance data ? lowa and SEER tissue repositories ? lowa mortality database ? lowa voter registration database ? lowa driver's license database ? SEER-Medicare database ? lowa Medicaid Database ? Cancer Care Outcomes Research &Surveillance Consortium ? Health Effectiveness Research Center ? Agricultural Health Study ? Center for the Heatth Effects of Environmental Contamination ? lowa Cancer Consortium The Population Research Core includes staff based in institutional centers of expertise, with intimate knowledge of the resources of these centers and how to harness them. Despite being a new shared research resource, in 2009, the Population Research Core provided services to 18 HCCC members with peer reviewed funding including investigators who are members of all 6 programs.

Public Health Relevance

The ability to analyze large population-based databases, and equally importantly, link them to each other, is vital for many cancer researchers. The Population Research Core provides access to such data to cancer researchers, and also provides the expertise needed to utilize this data which would, otherwise, not be available.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA086862-14
Application #
8640104
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
14
Fiscal Year
2014
Total Cost
$79,165
Indirect Cost
$28,740
Name
University of Iowa
Department
Type
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Holahan, Heather M; Farah, Ronda S; Fitz, Sara et al. (2018) Health-related quality of life in patients with cutaneous T-cell lymphoma? Int J Dermatol 57:1314-1319
Kurth, Ann E; Krist, Alex H; Borsky, Amanda E et al. (2018) U.S. Preventive Services Task Force Methods to Communicate and Disseminate Clinical Preventive Services Recommendations. Am J Prev Med 54:S81-S87
Gadupudi, Gopi S; Elser, Benjamin A; Sandgruber, Fabian A et al. (2018) PCB126 Inhibits the Activation of AMPK-CREB Signal Transduction Required for Energy Sensing in Liver. Toxicol Sci 163:440-453
Strouse, Christopher; Mangalam, Ashutosh; Zhang, Jun (2018) Bugs in the system: bringing the human microbiome to bear in cancer immunotherapy. Gut Microbes :1-4
White, Katherine A; Swier, Vicki J; Cain, Jacob T et al. (2018) A porcine model of neurofibromatosis type 1 that mimics the human disease. JCI Insight 3:
Tota, Joseph E; Engels, Eric A; Madeleine, Margaret M et al. (2018) Risk of oral tongue cancer among immunocompromised transplant recipients and human immunodeficiency virus-infected individuals in the United States. Cancer 124:2515-2522
Davis, Lauren Z; Cuneo, Michaela; Thaker, Premal H et al. (2018) Changes in spiritual well-being and psychological outcomes in ovarian cancer survivors. Psychooncology 27:477-483
Pearson, Jennifer L; Amato, Michael S; Papandonatos, George D et al. (2018) Exposure to positive peer sentiment about nicotine replacement therapy in an online smoking cessation community is associated with NRT use. Addict Behav 87:39-45
Mobley, Erin M; Foster, Kristin J; Terry, William W (2018) Identifying and Understanding the Gaps in Care Experienced by Adolescent and Young Adult Cancer Patients at the University of Iowa Hospitals and Clinics. J Adolesc Young Adult Oncol 7:592-603
Steinberg, Ryan L; Thomas, Lewis J; O'Donnell, Michael A (2018) Combination Intravesical Chemotherapy for Non-muscle-invasive Bladder Cancer. Eur Urol Focus 4:503-505

Showing the most recent 10 out of 1080 publications